Heidrick & Struggles Interviews UCB’s CEO

Heidrick & Struggles conducted an interview with Jean-Christophe Tellier, CEO of multinational biopharma company UCB. In the interview Jean-Christophe Tellier describes how focusing on patients is creating business opportunities and giving the organization a deeper sense of purpose.

How you would define your patient-focused approach?

Tellier: Traditionally, the patient has been relatively far from the pharma industry’s consciousness. If you think about the past 10 to 20 years, biopharma companies have been organized around key functions: for example, regulatory compliance, account management, and sales. None of these functions was really focused on the patient. A stronger patient focus reminds us every day that our purpose is helping people who suffer from chronic diseases to manage their condition and improve their quality of life. Now, our challenge is to take patient centricity — or what I call patient value — to the next level. It involves integrating the patient into every step of our activity chain, from research to marketing and sales, to drive better solutions and meet the patients’ diverse needs more effectively.

The full article is published on Heidrick & Struggles’ website. Read the full article.